THRA and breast cancer: This demonstrated that higher expression of both THRα and THRα1 are associated with a decrease in overall survival in women with triple negative (basal like) breast cancer (Fig. 1D), and also identified a novel prognostic association with THRα3 in basal-like and luminal A subtype (Fig. 1D).